248 related articles for article (PubMed ID: 16395832)
21. Levofloxacin vs. ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with haematological malignancies.
Timmers GJ; Simoons-Smit AM; Leidekker ME; Janssen JJ; Vandenbroucke-Grauls CM; Huijgens PC
Clin Microbiol Infect; 2007 May; 13(5):497-503. PubMed ID: 17263835
[TBL] [Abstract][Full Text] [Related]
22. Outpatient oral antibiotics for febrile neutropenic cancer patients.
Ouvrier MJ; Thery JC; Blot E
J Clin Oncol; 2006 Dec; 24(35):5614; author reply 5614-5. PubMed ID: 17158551
[No Abstract] [Full Text] [Related]
23. [Prevention and treatment of infections in patients with neutropenia and fever: the role of Pseudomonas aeruginosa].
Jiménez Martínez C; Ribera Santasusana JM; Giménez Pérez M; Batlle Masana M; Flores López A; Fernández-Avilés F; Sancho Cía JM; Millá Santos F; Feliu Frasnedo E
Rev Clin Esp; 1998 Sep; 198 Suppl 2():44-50. PubMed ID: 9844478
[No Abstract] [Full Text] [Related]
24. Antibiotic prophylaxis in neutropenic children with acute leukemia: Do the presently available data really support this practice?
Calitri C; Ruberto E; Castagnola E
Eur J Haematol; 2018 Dec; 101(6):721-727. PubMed ID: 30107054
[TBL] [Abstract][Full Text] [Related]
25. Empiric therapy for febrile neutropenia: what are the choices?
Aoun M
Expert Rev Anti Infect Ther; 2007 Jun; 5(3):507-15. PubMed ID: 17547514
[TBL] [Abstract][Full Text] [Related]
26. Treatment of patients with hematologic neoplasm, fever, and neutropenia.
Sepkowitz KA
Clin Infect Dis; 2005 Apr; 40 Suppl 4():S253-6. PubMed ID: 15768331
[TBL] [Abstract][Full Text] [Related]
27. Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors.
Oguz A; Karadeniz C; Citak EC; Cil V; Eldes N
Pediatr Hematol Oncol; 2006; 23(3):245-53. PubMed ID: 16517540
[TBL] [Abstract][Full Text] [Related]
28. Levofloxacin prophylaxis to prevent bacterial infection in chemotherapy-induced neutropenia in acute leukemia.
Rahman MM; Khan MA
Bangladesh Med Res Counc Bull; 2009 Dec; 35(3):91-4. PubMed ID: 20922911
[TBL] [Abstract][Full Text] [Related]
29. [Management of 315neutropenic febrile episodes in a cancer center].
Dutronc H; Billhot M; Dupon M; Eghbali H; Donamaria C; Dauchy FA; Reiffers J
Med Mal Infect; 2009 Jun; 39(6):388-93. PubMed ID: 19062208
[TBL] [Abstract][Full Text] [Related]
30. Episodes of fever and neutropenia in children with cancer in a tertiary care medical center in Turkey.
Tezcan G; Kupesiz A; Ozturk F; Ogunc D; Gultekin M; Yesilipek A; Hazar V
Pediatr Hematol Oncol; 2006; 23(3):217-29. PubMed ID: 16517538
[TBL] [Abstract][Full Text] [Related]
31. Infectious complications of chemotherapy-induced neutropenia: don't throw the baby out with the bathwater.
Dan M
Isr Med Assoc J; 2007 Jun; 9(6):463-5. PubMed ID: 17642396
[No Abstract] [Full Text] [Related]
32. Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions.
Leibovici L; Paul M; Cullen M; Bucaneve G; Gafter-Gvili A; Fraser A; Kern WV
Cancer; 2006 Oct; 107(8):1743-51. PubMed ID: 16977651
[TBL] [Abstract][Full Text] [Related]
33. [7/10 Antibiotic drug therapy and infectious risk].
Soins; 2007 Sep; (718):59-60. PubMed ID: 17970578
[No Abstract] [Full Text] [Related]
34. [Bacterial infections in neutropenic patients with cancer].
Matysiak M
Przegl Lek; 2003; 60 Suppl 5():54-7. PubMed ID: 14575008
[TBL] [Abstract][Full Text] [Related]
35. Clinical guidelines for the management of cancer patients with neutropenia and unexplained fever.
Jun HX; Zhixiang S; Chun W; Reksodiputro AH; Ranuhardy D; Tamura K; Matsumoto T; Lee DG; Purushotaman SV; Lim V; Ahmed A; Hussain Y; Chua M; Ong A; Liu CY; Hsueh PR; Lin SF; Liu YC; Suwangool P; Jootar S; Picazo JJ
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S128-32; discussion S133-40. PubMed ID: 16253480
[No Abstract] [Full Text] [Related]
36. [Against preventive antibiotic therapy in neutropenia].
Baro J; Richard C
Sangre (Barc); 1994 Jun; 39(3):165-6. PubMed ID: 7940044
[No Abstract] [Full Text] [Related]
37. Comment on: empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials.
Rolston KV; Bodey GP
J Antimicrob Chemother; 2006 Aug; 58(2):478; author reply 479-80. PubMed ID: 16698848
[No Abstract] [Full Text] [Related]
38. Neutropenia: clinical implications and modulation.
Glauser MP
Intensive Care Med; 2000; 26 Suppl 1():S103-10. PubMed ID: 10786966
[No Abstract] [Full Text] [Related]
39. The conundrum of fluoroquinolone prophylaxis.
Freifeld A; Sepkowitz K
Nat Clin Pract Oncol; 2006 Oct; 3(10):524-5. PubMed ID: 17019427
[No Abstract] [Full Text] [Related]
40. Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients.
Baskaran ND; Gan GG; Adeeba K
Ann Hematol; 2008 Jul; 87(7):563-9. PubMed ID: 18437382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
